RxDoctor Payments Data

Adam Lauer

Family Medicine · Brewer, MENPI 1841381381

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 48.6% of the total. Reporting peaked in 2023 at $1,009 and has fallen 81.5% since, to $186 in 2024. Among family medicine clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,570in general payments, 2019–2025

Across 131 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lundbeck LLC$327
  • Novartis$258
  • Eisai Inc.$177
  • Abbott$93
  • Ironshore Pharmaceuticals Inc.$80
  • plus $386 from 10 others

What the payments were for

  • Food & beverage$2,558100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,570 in reported general payments places this provider in the 95th percentile of 466 family medicine providers in Maine.

See all family medicine providers in Maine

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban42$60,131
TrulicityDulaglutide24$26,256
EntrestoSacubitril/Valsartan15$14,513
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,819
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$13,612
Celecoxib35$3,821
Insulin Lispro Kwikpen U-100Insulin Lispro16$2,839
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,230
Albuterol Sulfate HfaAlbuterol Sulfate45$1,824
Levothyroxine Sodium126$1,379
SynthroidLevothyroxine Sodium21$1,338
Atorvastatin Calcium150$1,236
Omeprazole64$895
Pantoprazole Sodium56$895
Novolin NInsulin Nph Human Isophane11$885

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$42$26,25624 claims
NovartisEntresto$258$14,51315 claims
GSKTrelegy Ellipta$70$13,81913 claims
AbbVieSynthroid$1,250$1,33821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 466 family medicine providers in Maine.

Other family medicine in Brewer

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →